RVLPQ (RVL Pharmaceuticals) Insider Ownership: 3.88 % (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVLPQ RVL Pharmaceuticals PLC RVLPQ
12 GF Score
Price $0.00
View Full Analysis

What is RVL Pharmaceuticals Insider Ownership?

RVL Pharmaceuticals RVLPQ -90.00% 12 Insider Ownership is 3.88 % as of Aug. 05, 2026. GuruFocus rates RVLPQ with a GF Score™ of 12/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RVL Pharmaceuticals's insider ownership is 3.88%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RVL Pharmaceuticals's Institutional Ownership is 0.17%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RVL Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 84.13%.

RVL Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for RVL Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RVL Pharmaceuticals Insider Ownership Chart

RVL Pharmaceuticals Historical Data

The historical data trend for RVL Pharmaceuticals can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 3.88 3.88 3.88 3.88 3.88 3.88 3.88 3.88 3.88 3.88
RVLPQ
12GF Score
RVL Pharmaceuticals PLC RVLPQ
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RVL Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 3.88 % mean?
RVL Pharmaceuticals (RVLPQ) has a Insider Ownership of 3.88 % as of Aug. 05, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on RVL Pharmaceuticals and its competitors.
Is RVL Pharmaceuticals' Insider Ownership too high?
RVL Pharmaceuticals' current Insider Ownership is 3.88 %. Overall, RVL Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does RVL Pharmaceuticals' Insider Ownership compare to SNPX and THAR?
RVL Pharmaceuticals' Insider Ownership of 3.88 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on RVL Pharmaceuticals and its competitors. RVL Pharmaceuticals's current Insider Ownership is 3.88 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RVL Pharmaceuticals stock overvalued right now?
RVL Pharmaceuticals (RVLPQ) has a current Insider Ownership of 3.88 %. The current Insider Ownership is 3.88 %. RVL Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For RVL Pharmaceuticals (RVLPQ), the current Insider Ownership is 3.88 % as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RVL Pharmaceuticals Business Description

Address 400 Crossing Boulevard, Bridgewater, NJ, USA, 08807
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
12GF Score

Get the complete analysis for RVLPQ

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price